Bowel cancer mainly refers to colorectal cancer, combined with liver metastases after resection and during chemotherapy.
Liver is the primary organ for distant metastasis of colorectal cancer, which is the main factor leading to death. Surgery remains an important treatment for patients with liver metastases from rectal cancer. Some studies claim that the 5-year overall survival rates of patients with surgically resectable and unresectable colorectal cancer liver metastases are 42% and 9%, respectively.
Colorectal cancer combined with liver metastasis belongs to the advanced stage of tumor, suggesting that the tumor cells have already entered into the blood circulation, and even if the metastatic lesions are removed and chemotherapy is administered, further metastasis cannot be ruled out. During chemotherapy, it is still necessary to closely observe the condition of various tissues and organs of the body, mainly combined with clinical symptoms and judged by imaging examination, and once metastasis occurs, do standardized treatment.
For colorectal cancer combined with liver metastasis, standardized treatment needs to be carried out in combination with specific pathological results and immunohistochemistry results, mainly through radiotherapy (cisplatin, etc.), targeted therapy or immunotherapy (bevacizumab, etc.) for integrated treatment to control the disease.
Diagnosed with tumor, we need to go to regular hospitals in time and follow the doctor’s instructions for comprehensive examination and standardized treatment.